Systematic literature review of health economic models developed for multiple myeloma to support future analyses

M Choon-Quinones, T Zelei, B Németh… - Journal of Medical …, 2023 - Taylor & Francis
Aims The goal of this study was to review the economic evaluations of health technologies in
multiple myeloma (MM) and provide guidance and recommendations for future health …

A systematic review of economic evaluations of treatment regimens in multiple myeloma

MM Asrar, DP Lad, S Prinja… - Expert Review of …, 2021 - Taylor & Francis
Background The expansion of advanced expensive therapeutic innovations for Multiple
Myeloma (MM) led to increased disclosure of economic evaluations. The present analysis …

Conceptual framework and methodological challenges for modeling effectiveness in oncology treatment sequence models

M Huang, S Ramsey, W Xue, J Xie, J Pellissier… - …, 2022 - Springer
In this review, we summarize the challenges faced by existing oncology treatment sequence
decision models and introduce a general framework to conceptualize such models. In the …

Chi phí-hiệu quả của các thuốc hiếm trong điều trị bệnh đa u tủy xương: Nghiên cứu tổng quan hệ thống

NĐH Nhung, TTĐ Linh, HTN Vũ - Journal of 108-Clinical …, 2021 - tcydls108.benhvien108.vn
Tóm tắt Mục tiêu: Đa u tủy xương là một bệnh ung thư huyết học, đặc trưng bởi sự tăng sinh
ác tính tế bào dòng plasma tiết ra protein đơn dòng trong huyết thanh và nước tiểu. Bộ Y tế …

Cost effectiveness of induction therapies differs long-term

V Qerimi - PharmacoEconomics & Outcomes News, 2018 - Springer
The cost effectiveness of induction therapies prior to autologous stem cell transplantation
(ASCT) in patients with multiple myeloma (MM) differs over a long-term versus short-term …